
- Get in Touch with Us
Last Updated: Apr 25, 2025 | Study Period: 2024-2030
A naturally occurring, palatable polysaccharide found in brown algae is alginic acid, often known as algin. It is hydrophilic and when hydrated turns into a viscous gum. Its salts are referred to as alginates when they contain metals like calcium and sodium. It might be white or yellowish-brown in colour.
It can be purchased in powdered, granular, or filamentous forms.Heartburn, gastric reflux, reflux oesophagitis, hiatus hernia, and other types of comparable gastric distress can all be treated with this medication.
Alginic acid is a naturally occurring hydrophilic colloidal polysaccharide derived from several brown seaweed (Phaeophyceae) species.
In order to produce a high viscosity, high pH gel, alginic acid can absorb its weight in water and other solutes at low pH. This prevents acid reflux into the oesophagus by creating a physical barrier floating in the gastric acid contents. Indigestion and gastroesophageal reflux disease can both be treated with it.
The Global Alginic acid market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.
VIVAPHARM Alginates - Alginic Acid,Alginates are organic polymers that can be obtained from various brown seaweeds. The nutraceutical, pharmaceutical, medical, and dentistry industries can all use these incredibly adaptable hydrocolloids.
Alginates are versatile and highly effective in various gel formation applications due to their ability to selectively bind a variety of multivalent cations.
The VIVAPHARM Alginates products can all be customised to fit the unique application needs of our clients. Alginates are frequently used for pill disintegration and pH-controlled release.
Alginates can also be utilised to create a "gel-raft" in anti-reflux applications. Capsule shells and flexible, clear, glossy film strips can both be made using the gelling properties.
Because of its ion exchange capabilities, it works well as a wound-protective agent.At Landerneau Marine Technologies SAS, alginates for VIVAPHARM are made.
The quickest transit routes are made possible by the brown algae's close proximity to the production site on the continental shelf. Local authorities control harvesting in order to maximise sustainability and in only specified regions. By-products from the manufacturing process are recycled or used as fertiliser for nearby agricultural produce.
Sl no | Topic |
1 | Market Segmentation |
2 | Scope of the report |
3 | Abbreviations |
4 | Research Methodology |
5 | Executive Summary |
6 | Introduction |
7 | Insights from Industry stakeholders |
8 | Cost breakdown of Product by sub-components and average profit margin |
9 | Disruptive innovation in the Industry |
10 | Technology trends in the Industry |
11 | Consumer trends in the industry |
12 | Recent Production Milestones |
13 | Component Manufacturing in US, EU and China |
14 | COVID-19 impact on overall market |
15 | COVID-19 impact on Production of components |
16 | COVID-19 impact on Point of sale |
17 | Market Segmentation, Dynamics and Forecast by Geography, 2024-2030 |
18 | Market Segmentation, Dynamics and Forecast by Product Type, 2024-2030 |
19 | Market Segmentation, Dynamics and Forecast by Application, 2024-2030 |
20 | Market Segmentation, Dynamics and Forecast by End use, 2024-2030 |
21 | Product installation rate by OEM, 2023 |
22 | Incline/Decline in Average B-2-B selling price in past 5 years |
23 | Competition from substitute products |
24 | Gross margin and average profitability of suppliers |
25 | New product development in past 12 months |
26 | M&A in past 12 months |
27 | Growth strategy of leading players |
28 | Market share of vendors, 2023 |
29 | Company Profiles |
30 | Unmet needs and opportunity for new suppliers |
31 | Conclusion |
32 | Appendix |